The Office of Neuroscience (ON) consists of five review divisions: The Division of Neurology I, the Division of Neurology II, the Division of Psychiatry, the Division of Anesthesiology, Addiction Medicine, Pain Medicine, and the Division of Pharm/Tox for Neuroscience (DPT-N). The Immediate office oversees the development, review, and regulation of applications as well as issues related to toxicology for drug and biologic products reviewed in these divisions.
Director: Billy Dunn, M.D.
Deputy Director: Eric Bastings, M.D.
Director of Project Management Staff: Paul David
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Neuroscience
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4346
Phone: (301) 796-2250
Fax: (301) 796-9842